Akademik Veri Yönetim Sistemi
Cumhuriyet Dental Journal, cilt.13, sa.1, ss.4-8, 2010 (Scopus)
Purpose: Bisphophonates are used in the management of metastatic bone cancers and osteoporosis. Intravenous (i.v) bisphosphonate (pamidronate, zoledronate) treatment causes the osteonecrosis of the jaws. In this case report, treatment of a referred patient, is presented. Case Report: A 51 years old female patient referred to our department with asymptomatic ostonecrosis in her left maxilla as a consequence of long term i.v. Bisphosphonates consumption. The treatment protocol included debridement, sequestrectomy and hyperbaric oxygen therapy. The patient has followed up periodically. Conclusion: Occurrence of bisphosphonate induced osteonecrosis became frequent by the increase of i.v. Biphosphonate usage. Therefore, the patients who will be treated by bisphosphonates must consult to a dentist and all dental treatments must be completed before the beginning of the therapy. By this way, the complications can be prevented.